Chromosomal translocation t(9;22)(p24;q11) appears to be recurrently associated with myeloid malignancy with aggressive course

被引:6
作者
Angelova, Svetlana [2 ]
Spassova, Sylva [3 ]
Toshkov, Stavri [2 ]
Shivarov, Velizar [1 ]
机构
[1] Natl Hematol Hosp, Lab Hematopathol & Immunol, Sofia 1756, Bulgaria
[2] Natl Hematol Hosp, Lab Cytogenet & Mol Biol, Sofia 1756, Bulgaria
[3] St Anna Hosp, Dept Internal Med, Sofia, Bulgaria
关键词
BCR-JAK2 FUSION GENE; LEUKEMIA; PATIENT;
D O I
10.3109/10428194.2011.580025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1809 / 1810
页数:2
相关论文
共 6 条
[1]   A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia [J].
Cirmena, Gabriella ;
Aliano, Stefania ;
Fugazza, Giuseppina ;
Bruzzone, Roberto ;
Garuti, Anna ;
Bocciardi, Renata ;
Bacigalupo, Andrea ;
Ravazzolo, Roberto ;
Ballestrero, Alberto ;
Sessarego, Mario .
CANCER GENETICS AND CYTOGENETICS, 2008, 183 (02) :105-108
[2]   A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q 11.2) translocation in a patient with a clinically typical chronic myeloid leukemia [J].
Griesinger, F ;
Hennig, H ;
Hillmer, F ;
Podleschny, M ;
Steffens, R ;
Pies, A ;
Wörmann, B ;
Haase, D ;
Bohlander, SK .
GENES CHROMOSOMES & CANCER, 2005, 44 (03) :329-333
[3]   PCM1-JAK2-fusion: a potential treatment target in myelodysplastic-myeloproliferative and other hemato-lymphoid neoplasms [J].
Hoeller, Sylvia ;
Walz, Christoph ;
Reiter, Andreas ;
Dirnhofer, Stephan ;
Tzankov, Alexandar .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (01) :53-62
[4]  
Lane Steven W, 2008, Br J Haematol, V142, P503, DOI 10.1111/j.1365-2141.2008.07164.x
[5]   Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates [J].
Patnaik, Mrinal M. ;
Knudson, Ryan A. ;
Gangat, Naseema ;
Hanson, Curtis A. ;
Pardanani, Animesh ;
Tefferi, Ayalew ;
Ketterling, Rhett P. .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (06) :518-524
[6]   JAK and MPL mutations in myeloid malignancies [J].
Tefferi, Ayalew .
LEUKEMIA & LYMPHOMA, 2008, 49 (03) :388-397